Trulieve Cannabis Corp. operates as a medical marijuana company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients via home delivery. It produces approximately 150 stock keeping units, including nasal sprays, capsules, concentrates, syringes, cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridge. As of January 14, 2019, the company operated 24 dispensaries. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone850-480-7955
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1,000
Next Earnings DateN/A
OptionableNot Optionable
Trulieve Cannabis (OTCMKTS:TCNNF) Frequently Asked Questions
What is Trulieve Cannabis' stock symbol?
Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."
What price target have analysts set for TCNNF?
5 analysts have issued 1-year target prices for Trulieve Cannabis' stock. Their forecasts range from $17.00 to $30.00. On average, they anticipate Trulieve Cannabis' share price to reach $21.60 in the next twelve months. This suggests a possible upside of 97.8% from the stock's current price. View Analyst Price Targets for Trulieve Cannabis.
What is the consensus analysts' recommendation for Trulieve Cannabis?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Trulieve Cannabis.
Has Trulieve Cannabis been receiving favorable news coverage?
Headlines about TCNNF stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Trulieve Cannabis earned a media sentiment score of -2.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Trulieve Cannabis.
Who are some of Trulieve Cannabis' key competitors?
Some companies that are related to Trulieve Cannabis include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
What other stocks do shareholders of Trulieve Cannabis own?
Who are Trulieve Cannabis' key executives?
Trulieve Cannabis' management team includes the folowing people:
- Ms. Kimberly Rivers, CEO & Chairman (Age 41)
- Mr. Mohan Srinivasan, Chief Financial Officer (Age 66)
- Mr. Jason Barry Pernell, Chief Information Officer (Age 41)
- Ms. Victoria Walker, Marketing Mang. (Age 34)
- Mr. Steven Ferrell, Sr. HR Director (Age 49)
How do I buy shares of Trulieve Cannabis?
Shares of TCNNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Trulieve Cannabis' stock price today?
One share of TCNNF stock can currently be purchased for approximately $10.92.
What is Trulieve Cannabis' official website?
How can I contact Trulieve Cannabis?
The company can be reached via phone at 850-480-7955.
MarketBeat Community Rating for Trulieve Cannabis (OTCMKTS TCNNF)
MarketBeat's community ratings are surveys of what our community members think about Trulieve Cannabis and other stocks. Vote "Outperform" if you believe TCNNF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TCNNF will underperform the S&P 500 over the long term. You may vote once every thirty days.
